Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics
Open Access
- 11 June 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Cell Biology
- Vol. 2013, 1-14
- https://doi.org/10.1155/2013/703545
Abstract
Transport of macromolecules across the blood-brain-barrier (BBB) requires both specific and nonspecific interactions between macromolecules and proteins/receptors expressed on the luminal and/or the abluminal surfaces of the brain capillary endothelial cells. Endocytosis and transcytosis play important roles in the distribution of macromolecules. Due to the tight junction of BBB, brain delivery of traditional therapeutic proteins with large molecular weight is generally not possible. There are multiple pathways through which macromolecules can be taken up into cells through both specific and nonspecific interactions with proteins/receptors on the cell surface. This review is focused on the current knowledge of receptor-mediated endocytosis/transcytosis and brain delivery using the Angiopep-2-conjugated system and the molecular Trojan horses. In addition, the role of neonatal Fc receptor (FcRn) in regulating the efflux of Immunoglobulin G (IgG) from brain to blood, and approaches to improve the pharmacokinetics of therapeutic biologics by generating Fc fusion proteins, and increasing the pH dependent binding affinity between Fc and FcRn, are discussed.Keywords
This publication has 106 references indexed in Scilit:
- Biochemical and functional characterization of a recombinant monomeric factor VIII–Fc fusion proteinJournal of Thrombosis and Haemostasis, 2013
- Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensionsProceedings of the National Academy of Sciences of the United States of America, 2012
- Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid TumorsMolecular Cancer Therapeutics, 2012
- Caveolae and the Regulation of EndocytosisPublished by Springer Science and Business Media LLC ,2012
- Receptor-Mediated Abeta Amyloid Antibody Targeting to Alzheimer’s Disease Mouse BrainMolecular Pharmaceutics, 2010
- Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood–brain barrierBrain Research, 2010
- Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion proteinJournal of Biotechnology, 2010
- Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin ReceptorMolecular Pharmaceutics, 2009
- Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyEuropean Journal of Pediatrics, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2006